Breast Lesion Localization Methods Market Growth And Industry Analysis By 2024

Posted by Rajkumar on October 22nd, 2019

Breast lesion localization methods are invasive or non-invasive techniques used to observe if lesions are palpable or non-palpable, as part of diagnosis of breast cancer. There are various types of breast lesion localization methods used globally to detect the abnormalities in terms of a lump or tumor in the breasts. Rampant increase in number of women opting for preventive screening tests for breast cancer creates a highly conducive environment for growth of the breast lesion localization methods market in the foreseeable future. Among various methods under breast lesion localization methods, radio occult localization lesion localization (ROLL) method is one of the fastest growing segments in terms of revenue share, which in turn is expected to underpin growth of the breast lesion localization methods market in the near future. ROLL is a precise method for early detection of breasts lesion, which includes three-dimensional localization of impalpable breast tumor in the body. It provides a unique advantage of high feasibility in connection with sentinel node biopsy in the same setting.

Request Sample Copy of Research Report @

Market Dynamics

Rapid strides made in technology and keen interest of healthcare providers to integrate cutting-edge solutions backed up by supportive government norms is fueling growth of this highly lucrative market, especially in developed regions. Furthermore, rise in prevalence of breast cancer globally, especially in Asia Pacific countries would inadvertently support market growth in the near future. In order to alleviate this spike in incidence rate of the malady, governments are focusing on strengthening the healthcare infrastructure through supportive regulatory norms and investments. Government and non-government organizations are actively focusing on developing awareness programs regarding breast cancer. Such initiatives are projected to bring about a rapid shift in market dynamics, with Asia Pacific taking on the mantle from North America to emerge as the largest market for breast lesion localization methods. According to The Economist Intelligence Unit Limited, in 2016, China had a comparatively low breast cancer burden by world standards, with 2012 age standardized ratio for incidence and mortality around 22.1 and 5.4 per 100,000 respectively. However, in India breast cancer incidence by global standards in 2012 age standardized ratio was around 25.8 per 100,000. Despite what the statistics tend to suggest, the extent of the disease has surged significantly unlike the steady rise as estimated earlier in 2009.

Market Taxonomy

This report segments the global breast lesion localization methods market on the basis of technique, end user, and geography. On the basis of technique, the market is categorized into wire guided localization, radio guided occult lesion localization, radioactive seed localization, magnetic tracers and ultrasound guided surgery. The wire guided localization method is further divided into core biopsy needles and fine aspiration needles. On the basis of end user, the market is divided into hospitals, ambulatory and surgical centers, diagnostics centers, oncology centers and others. Among all end users, hospitals segment dominated the breast lesion localization methods market, owing to rapid advancements in medical systems.

Key companies covered as a part of this study include Cook Medical Inc., Argon Medical Devices, Inc., C. R. Bard, Inc., SOMATEX Medical Technologies GmbH, Tsunami S.r.l, Sterylab Medical and Biopsybell Srl.


Large potential in untapped emerging economies is expected to fuel the growth in breast lesion localization methods market

Continuous rise in population in emerging economies such as India and increasing focus towards strengthening of the healthcare infrastructure in the region are expected to provide major growth traction for the breast lesion localization methods market in the near future. Furthermore, according to The Pink Initiative and Breast Cancer Statistics in India, in 2014, a significantly large population of patients below the age of 50 years suffered from breast cancer. The exact statistics represents that around 16% were in the age between 20 and 40 and 28% were in age between 40 and 50. Increasing awareness in such regions with high potential is expected to improve the time to market of highly effective and advanced products. The breast lesion localization methods market is expected to surge on a wave of renewed interest by healthcare providers and governments alike to tackle the menace of breast cancer in the not-so distant future.

Browse Complete Report For More Information @

About Coherent Market Insights


Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.


Contact Us


Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702


Like it? Share it!


About the Author

Joined: February 13th, 2019
Articles Posted: 590

More by this author